Register

Please register so we can remember your preferences, like your favourite suppliers and preferred news & events.


Supplier Login



New user? Register as a supplier


Forgot password?


My Account

Latest News in the pharma Industry

All

FDA approves Allergan's Rhofade cream, 1% for persistent facial erythema

FDA approves Allergan's Rhofade cream, 1% for persistent facial erythema

19 Jan 2017

Once-daily treatment reduces persistent facial erythema associated with rosacea through 12 hours.

Read more 
Opdivo demonstrated efficacy and improved survival in patients with previously treated advanced gastric cancer

Opdivo demonstrated efficacy and improved survival in patients with previously treated advanced gastric cancer

19 Jan 2017

Opdivo demonstrated a 37% reduction in the risk of death compared to placebo.

Read more 
I Holland hosts a live webinar to help customers  maximise their tablet tooling life

I Holland hosts a live webinar to help customers maximise their tablet tooling life

19 Jan 2017

Getting the most out of punches and dies with a simple and powerful tooling management system.

Read more 
Takeda and Ovid Therapeutics shake on innovative collaboration for TAK-935 in rare pediatric epilepsies

Takeda and Ovid Therapeutics shake on innovative collaboration for TAK-935 in rare pediatric epilepsies

19 Jan 2017

Collaboration between pharma and biotech underscores potential for new approaches to partnering.

Read more 
Sartorius Stedim Biotech supports mainstream adoption of Quality by Design

Sartorius Stedim Biotech supports mainstream adoption of Quality by Design

18 Jan 2017

Unique technology portfolio enables design space characterization, effective translation to the large-scale and enhanced process analytics.

Read more 
Lilly to acquire CoLucid for $960 million

Lilly to acquire CoLucid for $960 million

18 Jan 2017

Deal will enhance Lilly's existing pain management portfolio for migraine and adds potential near-term launch to its late-stage pipeline.

Read more 
Hikma receives FDA approval for generic equivalent to Xyrem

Hikma receives FDA approval for generic equivalent to Xyrem

18 Jan 2017

Company's subsidiary currently involved in patent litigation concerning this product.

Read more 
CPhI SEA adds six new features

CPhI SEA adds six new features

18 Jan 2017

The South East Asia exhibition now includes Investment Forum, Roadshows and Business Matchmaking.

Read more 
Merck opens production facility exclusively for meglumine

Merck opens production facility exclusively for meglumine

17 Jan 2017

Regulatory compliant, FDA-audited facility based in Mollet des Vallès, Spain.

Read more 
Biogen agrees to pay Forward Pharma $1.25 billion

Biogen agrees to pay Forward Pharma $1.25 billion

17 Jan 2017

The settlement and license agreement will strengthen Biogen's IP for leading oral therapy for multiple sclerosis.

Read more 
Selonterra publishes novel proprietary mechanism for APOE4 in Alzheimer’s disease

Selonterra publishes novel proprietary mechanism for APOE4 in Alzheimer’s disease

17 Jan 2017

Therapies targeted at this novel mechanism have the potential for disease-modification because they will address the genetic root cause of AD.

Read more 
Suliqua approved in the EU for the treatment of adults with type 2 diabetes

Suliqua approved in the EU for the treatment of adults with type 2 diabetes

17 Jan 2017

Suliqua will be delivered in two pre-filled SoloSTAR pens, providing different dosing options that may help answer individual market and patient insulin needs.

Read more 

Are you a supplier? Here's what we can do for you

Register now